Belle COVID-19 Statement to Our Valued Partners

I wanted to update you on the steps Belle is taking to help minimise the spread of COVID-19.

At Belle, our emphasis has always been on providing safe, effective products and great customer service. Our people and our partners are what is most important to us, and the health and safety of you and your clients remains our top priority.
We understand that you may have some questions when it comes to what we're doing in response to news surrounding COVID-19 (commonly known as novel coronavirus). Over the last several weeks, we have been following the guidelines and procedures outlined by Public Health England, WHO and regulatory agencies. We have now taken the decision to cancel all non-essential visits to hospitals and clinics. We will attempt to reschedule these as Skype calls or similar so we can remain in contact with you.

Should you require a rep to attend a case, please be assured that we will still available to assist you but we ask that you check with the theatre manager that they are happy for us to attend.

We have also instructed members of staff who are exhibiting symptoms of COVID-19 infection to stay home for 7 days and seek care from a medical provider if necessary.

We encourage you to review additional information and guidelines available at Public Health Englandwww.who.int or your local health department website.

Should you have any questions, please don’t hesitate to contact me. ben@belle.org.uk

Stay safe and healthy!

Ben

FDA Gives Motiva Implants the Thumbs Up

FDA Gives Motiva Implants the Thumbs Up

“I’m delighted to have the opportunity to participate in a study that has the potential to bring new insights to the breast aesthetic and reconstruction industry. Motiva Implants are innovative and differentiated, and we hope that these innovations will show significantly improved patient outcomes,” said Dr. Caroline Glicksman, a board certified plastic surgeon and Medical Director of the Motiva Implants clinical trial.

Read More